Matt LimbCardiovascularInternational consortium aims to develop precision approach for CVDAn international collaboration has begun to develop personalized treatments for patients with cardiovascular disease, combining genetic analysis and better integration of health data.February 21, 2024DiabetesStudy: Novel type of inhibitor may prevent microvascular diabetic complicationsA new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease, research suggests.February 15, 2024Alzheimer'sNHS lacks capacity for Alzheimer’s diagnostics, warn expertsMany thousands of patients in the U.K. could miss out on new treatments for Alzheimer’s disease because its National Health Service (NHS) lacks capacity for diagnostic tests, warn experts.February 14, 2024FDA ClearanceProscia receives 510(k) clearance from FDA for digital pathology solutionSoftware company Proscia has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology solution, Concentriq AP-Dx.February 12, 2024Brain CancerHigh hopes for accurate blood test detecting malignant brain tumorsA simple blood test to detect malignant brain tumors that can be hard to locate could spare many cancer patients risky and invasive surgery, say scientists.February 9, 2024Artificial IntelligenceOpentrons Labworks unveils AI-powered workflow toolsLab automation and robotics firm Opentrons Labworks Inc has unveiled new tools intended to enhance the efficiency of research across genomics, proteomics, cell biology, and synthetic biology.February 8, 2024CancerU.K. trial for mRNA-based cancer therapy beginsCancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.February 7, 2024SequencingU.K. Health Security Agency unveils five-year pathogen genomics strategyThe U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.February 1, 2024Alzheimer'sBlood test for Alzheimer’s shows high accuracy in studyScientists have hailed study results showing the high accuracy of a blood test that “could revolutionize” diagnosis of Alzheimer’s disease.January 31, 2024SepsisProgram to fight sepsis in LMICs launched at SCCM Congress, test data presentedIntensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.January 26, 2024Previous PagePage 3 of 9Next PageTop StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community